Weiss Multi Strategy Advisers LLC Guardant Health, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $938,363 - $1.28 Million	-43,483 Reduced 79.06%	11,517 $312,000
Q3 2023 Nov 14, 2023	SELL	$25.8 - $39.97 $535,866 - $830,176	-20,770 Reduced 27.41%	55,000 $1.63 Million
Q2 2023 Aug 14, 2023	SELL	$20.94 - $38.01 $1.54 Million - $2.8 Million	-73,615 Reduced 49.28%	75,770 $2.71 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $3.16 Million - $4.65 Million	137,885 Added 1199.0%	149,385 $3.5 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $292,560 - $687,470	11,500 New	11,500 $313,000
Q1 2021 May 14, 2021	SELL	$127.04 - $179.1 $317,600 - $447,750	-2,500 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $49,980 - $67,965	500 Added 25.0%	2,500 $322,000
Q3 2020 Nov 16, 2020	SELL	$80.32 - $111.8 $402,724 - $560,565	-5,014 Reduced 71.49%	2,000 $224,000
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $424,276 - $683,865	7,014 New	7,014 $569,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.83B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.